Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667160 · ClinicalTrials.gov registry record · Phase 4
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 426
- Enrollment target
NCT00667160: Completed Phase 4 study, sponsored by Astellas Pharma.
NCT00667160 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 426 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00667160, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 426 participants
- Enrollment target
Study Summary
A study to compare the safety and efficacy of Protopic and Elidel in treating mild Atopic Dermatitis in pediatric patients
Interventions
- DRUG tacrolimus ointment
- DRUG pimecrolimus cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2002-12 |
| Est. Completion | 2003-11 |
| Phase | Phase 4 |
What the finished NCT00667160 record still lists
NCT00667160 is an interventional study that assigns participants to a tested intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (18% lower).
The record links to 0 conditions, and to 2 interventions - of which tacrolimus ointment is the first listed.
NCT00667160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00667160 about?
NCT00667160 is a clinical study titled "Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis". A study to compare the safety and efficacy of Protopic and Elidel in treating mild Atopic Dermatitis in pediatric patients
What is the current status of trial NCT00667160?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 426 participants. The study started on 2002-12. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00667160?
The interventions under investigation include: tacrolimus ointment (DRUG), pimecrolimus cream (DRUG).
Who is sponsoring clinical trial NCT00667160?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00667160's enrollment target sits among peer trials
426 197th of 2000 higher than 1,804 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790784 · 426 participants · Phase 3
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia